4Sheikh JI,Cassidy EL,Doraiswamy PM,et al.Efficacy,safety,and tolerability of sertraline in patients with late-life depression and comorbid medical illness.J Am Geriatr Soc,2004,52(1):86-92.
5Schneider LS,Nelson JC,Clary CM,et al.An 8-week multicenter,parallel-group,double-blind,placebo-controlled study of sertraline in elderly outpatients with major depression.Am J Psychiatry,2003,160(7):1277-1285.
8Zanardi R,Cusin C,Rossini D,et al.Comparison of response to fluvoxamine in nondemented elderly compared to younger patients affected by major depression.J Clin Psychopharmacol,2003,23(6):535-539.
9Rossini D,Serretti A,Franchini L,et al.Sertraline versus fluvoxamine in the treatment of elderly patients with major depression:a double-blind,randomized trial.J Clin Psychopharmacol,2005,25(5):471-475.
10Phan VL,Urani A,Romieu P,et al.Strain differences in sigma-1 receptor-mediated behaviours are related to neurosteroid levels.Eur J Neurosci,2002,15(9):1523-1534.
4Deleon A, Patel NC, Crismon ML. arpiprazole : a comprehensive review of its pharmacology, clinical efficacy, and tolerability [J ]. Clin Ther,2004,26(5 ) :649-666.
5Aackeim HA. the definition and meaning of treatment-resistant depression [ J ]. J Clin Psychiatry,2001,62 ( suppl 16) : 10-17.
6Barbee JG, Conrad E J, Jamhour NJ. aripiprazole augmentation in treatment resistant depression[ J]. Ann Clin Psychiatry ,2004,16 (4) :189-194.
7Marcus RN, Mcquade RD, Carson WH, et al. the efficacy and safety of arlpiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, place- bo-controlled study[ J ]. J Clin Psychopharmacol, 2008,28 ( 2 ) : 156-165.
8Worthington JJ, Kinrys G, Wygant IE, et al. aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients [ J ]. Int Clin Psychopharmacol, 2005,20( 1 ) :9-11.
9Burris KD, Molski TF, Xu C, et al. aripiprazole, a novel antipsy- chotic, is a high-affinity partial agonist at human dopamine d2 re- ceptors [ J ]. J Pharmacol Exp Ther,2002,302 ( 1 ) : 381-359.
